| Product Code: ETC10113194 | Publication Date: Sep 2024 | Updated Date: Dec 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Zambia continued to rely heavily on imports of carcinoembryonic antigen, with top exporting countries being South Africa, India, Canada, USA, and Czech Republic. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market. However, there was a significant decline in the compound annual growth rate (CAGR) from 2020-2024 at -57.5%, with a further decrease in the growth rate from 2023-2024 at -46.72%. These trends suggest a challenging market environment for carcinoembryonic antigen imports into Zambia.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Zambia Carcinoembryonic Antigen Market Overview |
3.1 Zambia Country Macro Economic Indicators |
3.2 Zambia Carcinoembryonic Antigen Market Revenues & Volume, 2021 & 2031F |
3.3 Zambia Carcinoembryonic Antigen Market - Industry Life Cycle |
3.4 Zambia Carcinoembryonic Antigen Market - Porter's Five Forces |
3.5 Zambia Carcinoembryonic Antigen Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Zambia Carcinoembryonic Antigen Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Zambia |
4.2.2 Growing awareness about early cancer detection and screening |
4.2.3 Advancements in healthcare infrastructure and diagnostic technologies |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services in remote areas of Zambia |
4.3.2 High cost of cancer diagnostics and treatments |
4.3.3 Lack of skilled healthcare professionals specializing in cancer care |
5 Zambia Carcinoembryonic Antigen Market Trends |
6 Zambia Carcinoembryonic Antigen Market, By Types |
6.1 Zambia Carcinoembryonic Antigen Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Zambia Carcinoembryonic Antigen Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Zambia Carcinoembryonic Antigen Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.1.4 Zambia Carcinoembryonic Antigen Market Revenues & Volume, By Pancreatic Cancer, 2021- 2031F |
6.1.5 Zambia Carcinoembryonic Antigen Market Revenues & Volume, By Ovarian Cancer, 2021- 2031F |
6.1.6 Zambia Carcinoembryonic Antigen Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.1.7 Zambia Carcinoembryonic Antigen Market Revenues & Volume, By Thyroid Cancer, 2021- 2031F |
6.1.8 Zambia Carcinoembryonic Antigen Market Revenues & Volume, By Others, 2021- 2031F |
7 Zambia Carcinoembryonic Antigen Market Import-Export Trade Statistics |
7.1 Zambia Carcinoembryonic Antigen Market Export to Major Countries |
7.2 Zambia Carcinoembryonic Antigen Market Imports from Major Countries |
8 Zambia Carcinoembryonic Antigen Market Key Performance Indicators |
8.1 Number of cancer screening campaigns conducted annually |
8.2 Percentage increase in early cancer detection rates |
8.3 Adoption rate of new diagnostic technologies in cancer centers |
8.4 Number of healthcare facilities offering cancer care services |
8.5 Patient survival rates for cancer cases detected in early stages |
9 Zambia Carcinoembryonic Antigen Market - Opportunity Assessment |
9.1 Zambia Carcinoembryonic Antigen Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Zambia Carcinoembryonic Antigen Market - Competitive Landscape |
10.1 Zambia Carcinoembryonic Antigen Market Revenue Share, By Companies, 2024 |
10.2 Zambia Carcinoembryonic Antigen Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |